AntoXa

Life-saving biodefense solutions

  • About Us
    • Management Team
  • Products
  • Investors
  • News
  • Contact
You are here: Home / Contact

Contact

To learn more about AntoXa Corporation, please contact:

Don Stewart, CEO
don.stewart@antoxacorp.com
416.452.7242

Ashley J. Meyers, President and Chief Operating Officer
ashley.meyers@antoxacorp.com
905.852.0850
1920 Yonge Street, Suite 200 Toronto, Ontario, Canada, M4S 3E2

For media inquiries, please contact:

Stacey Curry Gunn
Director of Communications
stacey.curry.gunn@antoxacorp.com
519.827.1131

Questions? Drop us a line via our Contact Form:

Latest News

U.S. Patent Granted for Made-in-Canada Ricin Antibody Technology

February 27, 2023

GUELPH, Ont., CANADA, Feb. 27, 2023 — The U.S. Patent Office has granted ...
Read more >

AntoXa Corporation awarded contract extension with federal government to develop plant-made protein for potential coronavirus therapy

August 17, 2021

DRDC-funded project aims to develop recombinant human ...
Read more >

AntoXa awarded federal government contract for anti-nerve agent enzyme

March 20, 2019

GUELPH, Ontario, Canada, March 20, 2019 — AntoXa Corporation has been ...
Read more >

About Us

Plant-made biopharmaceuticals for a safer world. AntoXa Corporation is a Canadian biopharmaceutical company developing medical countermeasures to protect military and civilian personnel from biological and chemical agents that might be used in terrorist attacks, as well as outbreaks of naturally ...
Read more >

Global Demand for Biodefense Therapeutics

Governments are investing billions of dollars preparing for potential bioterrorism attacks and ...
Read more >

Subscribe to our Newsletter

vivoXPRESS® MANUFACTURING SYSTEM
The plant-based vivoXPRESS® manufacturing platform offers several advantages over the mammalian and bacterial cell culture systems used to produce most recombinant protein pharmaceuticals. Here’s how it works.

BioPharming Info Centre

Biopharming, also known as plant molecular farming, refers to the use of genetically modified plants to produce a wide range of pharmaceuticals and industrial products. See our Biopharming Info Centre to Learn more about the science and history of using plants to produce complex therapeutic proteins.

Copyright © 2023 · AntoXa Corporation | Site by Curry Gunn & Associates